{"success":true,"data":{"pressRelease":{"id":"158032","rtpr_id":"nGNX3zw1vX-20261001","ticker":"CLOV","exchange":"NASDAQ","all_tickers":["CLOV"],"title":"Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value","author":"Globe Newswire","published_at":"2026-10-01T12:00:01.254Z","article_body":"WILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments,\nCorp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”),\na physician enablement technology company committed to bringing access to\ngreat healthcare to everyone on Medicare, today announced its 2027 Medicare\nAdvantage (MA) plan offerings, with a continued focus on PPO choice,\naffordable access to preventive care and meaningful member value. Clover’s\nMedicare Advantage model is powered by Clover Assistant (CA), which is\ndesigned to give physicians across Clover’s broad provider network access to\nrelevant patient information to identify care needs and support\nbetter-informed clinical decisions.\n\nClover Health’s 2027 portfolio provides options for members with different\nhealthcare needs and financial circumstances including:\n* $0 to low premium PPO with broad provider choice and no referrals required*\n* $0 primary care physician (PCP) in-network copays\n* Some of the lowest specialist copays in the industry\n* $0 lab services at preferred providers\n* Routine dental, vision, OTC and gym benefits across all plans\n* Up to $400 in LiveHealthy Rewards for eligible healthy activities\n* Options that pair well with Extra Help/PAAD as well as an MA only plan\n* Clover Assistant-powered care model, designed to help physicians identify\ncare needs and make better-informed clinical decisions\n“Medicare Beneficiaries are once again navigating a market where plans are\nchanging, choices can be harder to understand, and affordability matters more\nthan ever,” said Jamie Reynoso, CEO of Medicare Advantage at Clover Health.\n“Our teams have been deliberate about protecting meaningful PPO choice and\naccess to care for our members, and our ability to pair that flexibility and\nvalue with top-ranked clinical quality shows what this model can deliver even\nas others in the industry pull back.”\n\nHigh-Choice PPO Access in a Changing MA Market\nAs MA organizations reassess plan footprints, benefits and distribution\nstrategies, Clover continues to emphasize PPO choice and flexibility. For\n2027, Clover will offer a commissionable $0-premium PPO, making it one of\nrelatively few plans to offer this combination in its markets.\n\nTop-Ranked Clinical Quality, Powered by Clover Assistant\nPowered by Clover Assistant, Clover’s flagship PPO has ranked #1 nationally\namong PPO plans on core HEDIS clinical quality measures for two consecutive\nyears, demonstrating the strength of a care model designed to surface relevant\ninformation for physicians to identify care needs and support better-informed\nclinical decisions.(1)\n\nClover’s locally focused strategy complements this model. Its 2027\ngeographic footprint remains consistent with 2026, with New Jersey and Georgia\ncontinuing as core markets where Clover is focused on deepening relationships\namong members, physicians and local healthcare resources.\n\nThe 2027 Annual Enrollment Period runs from October 15 through December 7,\n2026. Clover Health plans will be available to 5.2 million Medicare-eligible\nbeneficiaries within 203 counties across five states. Plans available based on\nlocation are available to view here.\n(https://www.globenewswire.com/Tracker?data=bPhTtaA8aT_rk4DieWgQGGu1R8aWSA3YPCSekIMEaPKXHNut2ljVdwhYCp6CEjP1OZB5aPFH5ywxwMbAI7IAoDeaDhrkhTnzaxZ_vXCTQhw=)\n\nAbout Clover Health:\n\nClover Health (Nasdaq: CLOV) is a physician enablement technology company\ncommitted to bringing access to great healthcare to everyone on Medicare. This\nincludes a focus on seniors who have historically lacked access to affordable,\nhigh-quality healthcare. Our strategy is powered by our software platform,\nClover Assistant, which is designed to aggregate patient data from across the\nhealthcare ecosystem to support clinical decision-making and improve health\noutcomes through the early identification and management of chronic disease.\nFor our members, we provide PPO and HMO Medicare Advantage plans in several\nstates, with a differentiated focus on our flagship wide-network, high-choice\nPPO plans. For healthcare providers outside Clover Health's Medicare Advantage\nplan, we extend the benefits of our data-driven technology platform to a wider\naudience via our subsidiary, Counterpart Health, and aim to enable enhanced\npatient outcomes and reduced healthcare costs on a nationwide scale. Clover\nHealth has published data demonstrating the technology’s impact on\nMedication Adherence\n(https://www.globenewswire.com/Tracker?data=pK54pDb7NMaACZ4sd4OuV7uXvLUlpXU75we-W6kAKJwkQanKSnl2G_YhMeB-HNb_2HkBmx95x-ZGcPpXr52efgHQQLFiQ9jECFOWDw-OAxUGraExRq9PkuszMV6SFfNs0eVW9ehov5mxKLJXD-zk-z3Zvmn9vvU5pRoUmijIjHqhreVQ6bh-N_PkOwmlkawm-_eDRp0UNw7tUbBVMZpLn7Jpxl457ruaewqCuvHdIMsbN2RwOhEO-CwRqi9qQ9hP3TiOMBANC2urIAbCtnO-hSygm5DoxT6zfeMAaVTb4iJuMwNBKWdfYoB7N187WUiP51tDJHyN3cXmUMrVgy8JyI95mr2-ULcBEFsbbvOa2qyEEzPPEbzZZ4KKCuQVcMZxwE0ghCoT-XKUaDsePUWt2JSzBbtS4v8bWAJRgTmJJQYGdAgV6oplVBqNcSD1hBwR5hKWwns25U_ugF2QA9t0jpPG3pW4_5fUfSt0_z5ku7d3GzWXukWA6kZ088fiqWiF8DvOCweE7T_lrxHgtnAbwg==),\nCongestive Heart Failure\n(https://www.globenewswire.com/Tracker?data=h6wTIvph3tNXUri4c2c_URO960iAMw1ZdfBlwt8ZPWGReH34p8scbnc7_Zx1D5-CNibIPnLexwLVTL-ToUs9j1u5LR9aoT51tgswlD1lrKNnhkBWiHqH6XHq_6acREfIqAvpANpz-GKhwFz2mYuKl_cyDla41amFbM3pH1BrMd0_lwwiX1kDVBwyzm7CgNdo9IUaDMWH2bM7nxh1S4sLY4tSHHq-CiWafVggWk2_hjbm-tgwSG_NVmKU2TxSpCYHCYRo5mrSGTNSvmMWY2jUEhC1-JfHyObsERjibasyg-zBGSb23-on95sEICuuRimaoL4GT9KjHl8MTSFxg5WeOvOOOdYpKE59gNgpurJOAtRSdzlY88ZEqj0OaVFsWuAHfWItgUUWlCOCFS82605yzWGSWsSY4OGYJ5renSZur6XrWFjxfEk7IJqRVRvunfhtzmTa3LNrFUtqJYqiO91gg_J4-2Tba-uIYEgzuJxNicMXxnIlNwLfVr_SBPVB_JIJ-Bv072wLKpSZePiALAJSuHWLO1U_RXUVO-dTyo2ErZZGL8n6It4KokjXJy6OzAR3Ed91uwrH7ONb_fc79t4VT_jZbM-wzVGE2LELTbmhevk=),\nChronic Obstructive Pulmonary Disease\n(https://www.globenewswire.com/Tracker?data=nDqJXhWU85i0uAFVX7SZMssSuI8nu-hHJQhAr4YHY6lKuVYzgANXTMB-Q-_I6bRJeEnymqXdKbmuVjAQAPKPN9qqMc4WoJEYBCqbguugGHbKOOeiu3pEPnHrYEAoyZlrrhtSS3FSwiD6tyMLtS9YP-C50IY8gw6sLvvT5oolGuvaztpWzPGAm8mYYH0BQfyGO7ck1lYw-LTtwIg0_2FOxyP_yX_gFVqiZaQMF5uo-8hfjmZQCwK_SCvnpcPP_nerY7F_JT-CapjnICfHZRMt7BuJr9MifkvTXqw1kCCBBiuF9LIB8vxId81g5SmTsziVIedrdae8RPkOkPhJg2xGKLBNNyk1-0JX_paDBldT3gZuw-cetBmWdosbVmMn1MI6dgB2bL8bnyu1g2KvqabBCw==),\nand in Underserved Populations\n(https://www.globenewswire.com/Tracker?data=0Ys2SLctUoAgWyTGgAyjTrp5ob3CtUFfsu01IK2DVf2TShSZjP87sj5nBG6Jlz2hCJNjq27MglFiW8zt2KQPRH-Trrh6uaLWHWPeX_YphPAbFmodvKjHchKG9UAxP5rJIwJ8F1deUvccUeJcoOyxF3Y1zCbe4mKwyg6re8aBzig7VI90Q2CZXpzjsETZcLA4nounfnWH0kDvZFlPcA60Vgbn6_LHEoA0U_diJDp2MJmc0oaCamBpZH7A6ADu-WxBACF6yfedc6QDb0HKuLF2CKUvVR_Qfy0DieMhwFKvb0b08OHjE9_UDyNO1ta4ncOjJeMV0cb_kRPSS4TLuYOWdwdVf5pqX2GuXPvKNiIII5_2Mz6ml0IE_De0M4wCiJSRYItWbqGx-ze76JOulVoMfsraZSrirLS0t-GAgw9VejDnbdpDCbEKNcKDJHmOyCJM1DK1YHzWpSazziXMRXb12A0yHPRPtEE0e6O9piJwdOXPt8ercPBE42EHz2rTlZ4IXP1-O-zAQnmkTnC0nEB_2tWTlM5GsWJ-PiUD3t3jVRQQzdAzp1eGR3mla9tR0xL2vKcyTxFtTNV0kIW75zGPOWEOpHz98bst77Lt0XBvTQD1lN1-bI2sMdm2vJ2WC_YiVNuwaJcH157ugYxk28_LaTzvl5ylbe007LSgFqmdm2dqClaQ-9MsPm-MYOfPojn53C_eZtt4SC-pdRqwmpEPnlkkPt4ZhdeRDQ9kogLnYkWqTVhtEFXStr_2gNlCKgXsL0vG42WofmGHoJrAIz2hvW73imFLLNG0KDyRf6IklCVzJuwLp-vshiAkMYdTt1btP-ckZlMz50vNUP43aZakqA==)\nas well as the earlier identification and management of Diabetes\n(https://www.globenewswire.com/Tracker?data=tS0h3tciHcAciL2UhZmj5zydS1m70HFUr82u2r8GbgFz2Pa0qlFRL7j3b2aAvfpycHIb-mt0-ANAHFAmBuIaAh44W3SpoTBxk4hQnHuK-rFACdOZIt222t8gwxEkZRM7rtPFab-zGZTgYoRZVfHtbcKdb7zWxGD1T-feQm6sErHW6-gE-JvRbGeSowDSWd4VC2UHdWMLCoXmncPtFWvzuCLxS7km2uZZlTRhV5E1icqTwcXATopg9LWAWY2kVtGF6JEdUV4ySns_IOVmkmF366Wo8jKi5ZAFqooeqN-FnTHNx7gIA8I2B81yiE2M2CPUgEu0HiI-q127Lr8VL3CJYYStvRFmFfMG8LMUowdloQId7a4stdSv9agstUjBxaCaf3O0rNmjAoU4U4L1Jz6jnjPCuB7SvSbL4Ts8YADw4t9EeF7kU5IKN2OmjWCauQUQUnlS5luNvJL9ntjhPztU9a4H9qoLaxp7qd16fwhas8o=)\nand Chronic Kidney Disease\n(https://www.globenewswire.com/Tracker?data=nDqJXhWU85i0uAFVX7SZMmRexYoiUxODbHSY9bANTNvmQDUmmdunWwyjgATnE582O5Rvxt2g8jDSwJBMjdi4I7d-sQYqS0o1Y48I1eP3SHtj3xSYlk2dGssNeLAn3ndJr-DA6NVeLv08zxyzOwCm_tHAsn1Q7L_1NP60z45i3s5H5RhmzpaHTRfB5Ol-X2PLPy9JelJOVXXK56j3EKK1j3E84xyfsDkoAUl1PrBB0VmToHkE9WDclHqxDkWS7-6IzRPyCdQ67I_myMdomJ1D1wlHETx9q6ELH__nRFfd_tgH63NZpPmK5Kxra7ehxXQZG9GBFIQeKMaiHKTx64WkvOOcPPjpe0DS9UrB7vH0X0LspPy7S-oPzgwWxevY77-gItIY6Gp0OqjYvrpaqqANwB3TBD5jbu9_ZSZsQVvN5TffVHUqjfGcY35Fdkv2FqSU).\n\nInvestor Relations:\nRyan Schmidt\ninvestors@cloverhealth.com\n\nPress Inquiries:\npress@cloverhealth.com\n\n*Out-of-network/non-contracted providers are under no obligation to treat\nClover members, except in emergency situations.\n\nClover Health is a Preferred Provider Organization (PPO) and a Health\nMaintenance Organization (HMO) with a Medicare contract. Enrollment in Clover\nHealth depends on contract renewal.\n\nY0129_26EX091_M\n\n(1) This analysis focuses on performance by non-SNP PPO plans with over 2,000\nlives as of September 1, 2025 on HEDIS measures applicable to non-SNPs that\nwere used for CMS’s MY 2024 Star ratings, applying the measure ranges used\nby CMS.\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/1a48a25b-b654-4d62-adb3-d1a776346264)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX3zw1vX-20261001","title":"Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value","author":"Globe Newswire","ticker":"CLOV","created":"2026-10-01T12:00:01.254Z","tickers":["CLOV"],"exchange":"NASDAQ","article_body":"WILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments,\nCorp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”),\na physician enablement technology company committed to bringing access to\ngreat healthcare to everyone on Medicare, today announced its 2027 Medicare\nAdvantage (MA) plan offerings, with a continued focus on PPO choice,\naffordable access to preventive care and meaningful member value. Clover’s\nMedicare Advantage model is powered by Clover Assistant (CA), which is\ndesigned to give physicians across Clover’s broad provider network access to\nrelevant patient information to identify care needs and support\nbetter-informed clinical decisions.\n\nClover Health’s 2027 portfolio provides options for members with different\nhealthcare needs and financial circumstances including:\n* $0 to low premium PPO with broad provider choice and no referrals required*\n* $0 primary care physician (PCP) in-network copays\n* Some of the lowest specialist copays in the industry\n* $0 lab services at preferred providers\n* Routine dental, vision, OTC and gym benefits across all plans\n* Up to $400 in LiveHealthy Rewards for eligible healthy activities\n* Options that pair well with Extra Help/PAAD as well as an MA only plan\n* Clover Assistant-powered care model, designed to help physicians identify\ncare needs and make better-informed clinical decisions\n“Medicare Beneficiaries are once again navigating a market where plans are\nchanging, choices can be harder to understand, and affordability matters more\nthan ever,” said Jamie Reynoso, CEO of Medicare Advantage at Clover Health.\n“Our teams have been deliberate about protecting meaningful PPO choice and\naccess to care for our members, and our ability to pair that flexibility and\nvalue with top-ranked clinical quality shows what this model can deliver even\nas others in the industry pull back.”\n\nHigh-Choice PPO Access in a Changing MA Market\nAs MA organizations reassess plan footprints, benefits and distribution\nstrategies, Clover continues to emphasize PPO choice and flexibility. For\n2027, Clover will offer a commissionable $0-premium PPO, making it one of\nrelatively few plans to offer this combination in its markets.\n\nTop-Ranked Clinical Quality, Powered by Clover Assistant\nPowered by Clover Assistant, Clover’s flagship PPO has ranked #1 nationally\namong PPO plans on core HEDIS clinical quality measures for two consecutive\nyears, demonstrating the strength of a care model designed to surface relevant\ninformation for physicians to identify care needs and support better-informed\nclinical decisions.(1)\n\nClover’s locally focused strategy complements this model. Its 2027\ngeographic footprint remains consistent with 2026, with New Jersey and Georgia\ncontinuing as core markets where Clover is focused on deepening relationships\namong members, physicians and local healthcare resources.\n\nThe 2027 Annual Enrollment Period runs from October 15 through December 7,\n2026. Clover Health plans will be available to 5.2 million Medicare-eligible\nbeneficiaries within 203 counties across five states. Plans available based on\nlocation are available to view here.\n(https://www.globenewswire.com/Tracker?data=bPhTtaA8aT_rk4DieWgQGGu1R8aWSA3YPCSekIMEaPKXHNut2ljVdwhYCp6CEjP1OZB5aPFH5ywxwMbAI7IAoDeaDhrkhTnzaxZ_vXCTQhw=)\n\nAbout Clover Health:\n\nClover Health (Nasdaq: CLOV) is a physician enablement technology company\ncommitted to bringing access to great healthcare to everyone on Medicare. This\nincludes a focus on seniors who have historically lacked access to affordable,\nhigh-quality healthcare. Our strategy is powered by our software platform,\nClover Assistant, which is designed to aggregate patient data from across the\nhealthcare ecosystem to support clinical decision-making and improve health\noutcomes through the early identification and management of chronic disease.\nFor our members, we provide PPO and HMO Medicare Advantage plans in several\nstates, with a differentiated focus on our flagship wide-network, high-choice\nPPO plans. For healthcare providers outside Clover Health's Medicare Advantage\nplan, we extend the benefits of our data-driven technology platform to a wider\naudience via our subsidiary, Counterpart Health, and aim to enable enhanced\npatient outcomes and reduced healthcare costs on a nationwide scale. Clover\nHealth has published data demonstrating the technology’s impact on\nMedication Adherence\n(https://www.globenewswire.com/Tracker?data=pK54pDb7NMaACZ4sd4OuV7uXvLUlpXU75we-W6kAKJwkQanKSnl2G_YhMeB-HNb_2HkBmx95x-ZGcPpXr52efgHQQLFiQ9jECFOWDw-OAxUGraExRq9PkuszMV6SFfNs0eVW9ehov5mxKLJXD-zk-z3Zvmn9vvU5pRoUmijIjHqhreVQ6bh-N_PkOwmlkawm-_eDRp0UNw7tUbBVMZpLn7Jpxl457ruaewqCuvHdIMsbN2RwOhEO-CwRqi9qQ9hP3TiOMBANC2urIAbCtnO-hSygm5DoxT6zfeMAaVTb4iJuMwNBKWdfYoB7N187WUiP51tDJHyN3cXmUMrVgy8JyI95mr2-ULcBEFsbbvOa2qyEEzPPEbzZZ4KKCuQVcMZxwE0ghCoT-XKUaDsePUWt2JSzBbtS4v8bWAJRgTmJJQYGdAgV6oplVBqNcSD1hBwR5hKWwns25U_ugF2QA9t0jpPG3pW4_5fUfSt0_z5ku7d3GzWXukWA6kZ088fiqWiF8DvOCweE7T_lrxHgtnAbwg==),\nCongestive Heart Failure\n(https://www.globenewswire.com/Tracker?data=h6wTIvph3tNXUri4c2c_URO960iAMw1ZdfBlwt8ZPWGReH34p8scbnc7_Zx1D5-CNibIPnLexwLVTL-ToUs9j1u5LR9aoT51tgswlD1lrKNnhkBWiHqH6XHq_6acREfIqAvpANpz-GKhwFz2mYuKl_cyDla41amFbM3pH1BrMd0_lwwiX1kDVBwyzm7CgNdo9IUaDMWH2bM7nxh1S4sLY4tSHHq-CiWafVggWk2_hjbm-tgwSG_NVmKU2TxSpCYHCYRo5mrSGTNSvmMWY2jUEhC1-JfHyObsERjibasyg-zBGSb23-on95sEICuuRimaoL4GT9KjHl8MTSFxg5WeOvOOOdYpKE59gNgpurJOAtRSdzlY88ZEqj0OaVFsWuAHfWItgUUWlCOCFS82605yzWGSWsSY4OGYJ5renSZur6XrWFjxfEk7IJqRVRvunfhtzmTa3LNrFUtqJYqiO91gg_J4-2Tba-uIYEgzuJxNicMXxnIlNwLfVr_SBPVB_JIJ-Bv072wLKpSZePiALAJSuHWLO1U_RXUVO-dTyo2ErZZGL8n6It4KokjXJy6OzAR3Ed91uwrH7ONb_fc79t4VT_jZbM-wzVGE2LELTbmhevk=),\nChronic Obstructive Pulmonary Disease\n(https://www.globenewswire.com/Tracker?data=nDqJXhWU85i0uAFVX7SZMssSuI8nu-hHJQhAr4YHY6lKuVYzgANXTMB-Q-_I6bRJeEnymqXdKbmuVjAQAPKPN9qqMc4WoJEYBCqbguugGHbKOOeiu3pEPnHrYEAoyZlrrhtSS3FSwiD6tyMLtS9YP-C50IY8gw6sLvvT5oolGuvaztpWzPGAm8mYYH0BQfyGO7ck1lYw-LTtwIg0_2FOxyP_yX_gFVqiZaQMF5uo-8hfjmZQCwK_SCvnpcPP_nerY7F_JT-CapjnICfHZRMt7BuJr9MifkvTXqw1kCCBBiuF9LIB8vxId81g5SmTsziVIedrdae8RPkOkPhJg2xGKLBNNyk1-0JX_paDBldT3gZuw-cetBmWdosbVmMn1MI6dgB2bL8bnyu1g2KvqabBCw==),\nand in Underserved Populations\n(https://www.globenewswire.com/Tracker?data=0Ys2SLctUoAgWyTGgAyjTrp5ob3CtUFfsu01IK2DVf2TShSZjP87sj5nBG6Jlz2hCJNjq27MglFiW8zt2KQPRH-Trrh6uaLWHWPeX_YphPAbFmodvKjHchKG9UAxP5rJIwJ8F1deUvccUeJcoOyxF3Y1zCbe4mKwyg6re8aBzig7VI90Q2CZXpzjsETZcLA4nounfnWH0kDvZFlPcA60Vgbn6_LHEoA0U_diJDp2MJmc0oaCamBpZH7A6ADu-WxBACF6yfedc6QDb0HKuLF2CKUvVR_Qfy0DieMhwFKvb0b08OHjE9_UDyNO1ta4ncOjJeMV0cb_kRPSS4TLuYOWdwdVf5pqX2GuXPvKNiIII5_2Mz6ml0IE_De0M4wCiJSRYItWbqGx-ze76JOulVoMfsraZSrirLS0t-GAgw9VejDnbdpDCbEKNcKDJHmOyCJM1DK1YHzWpSazziXMRXb12A0yHPRPtEE0e6O9piJwdOXPt8ercPBE42EHz2rTlZ4IXP1-O-zAQnmkTnC0nEB_2tWTlM5GsWJ-PiUD3t3jVRQQzdAzp1eGR3mla9tR0xL2vKcyTxFtTNV0kIW75zGPOWEOpHz98bst77Lt0XBvTQD1lN1-bI2sMdm2vJ2WC_YiVNuwaJcH157ugYxk28_LaTzvl5ylbe007LSgFqmdm2dqClaQ-9MsPm-MYOfPojn53C_eZtt4SC-pdRqwmpEPnlkkPt4ZhdeRDQ9kogLnYkWqTVhtEFXStr_2gNlCKgXsL0vG42WofmGHoJrAIz2hvW73imFLLNG0KDyRf6IklCVzJuwLp-vshiAkMYdTt1btP-ckZlMz50vNUP43aZakqA==)\nas well as the earlier identification and management of Diabetes\n(https://www.globenewswire.com/Tracker?data=tS0h3tciHcAciL2UhZmj5zydS1m70HFUr82u2r8GbgFz2Pa0qlFRL7j3b2aAvfpycHIb-mt0-ANAHFAmBuIaAh44W3SpoTBxk4hQnHuK-rFACdOZIt222t8gwxEkZRM7rtPFab-zGZTgYoRZVfHtbcKdb7zWxGD1T-feQm6sErHW6-gE-JvRbGeSowDSWd4VC2UHdWMLCoXmncPtFWvzuCLxS7km2uZZlTRhV5E1icqTwcXATopg9LWAWY2kVtGF6JEdUV4ySns_IOVmkmF366Wo8jKi5ZAFqooeqN-FnTHNx7gIA8I2B81yiE2M2CPUgEu0HiI-q127Lr8VL3CJYYStvRFmFfMG8LMUowdloQId7a4stdSv9agstUjBxaCaf3O0rNmjAoU4U4L1Jz6jnjPCuB7SvSbL4Ts8YADw4t9EeF7kU5IKN2OmjWCauQUQUnlS5luNvJL9ntjhPztU9a4H9qoLaxp7qd16fwhas8o=)\nand Chronic Kidney Disease\n(https://www.globenewswire.com/Tracker?data=nDqJXhWU85i0uAFVX7SZMmRexYoiUxODbHSY9bANTNvmQDUmmdunWwyjgATnE582O5Rvxt2g8jDSwJBMjdi4I7d-sQYqS0o1Y48I1eP3SHtj3xSYlk2dGssNeLAn3ndJr-DA6NVeLv08zxyzOwCm_tHAsn1Q7L_1NP60z45i3s5H5RhmzpaHTRfB5Ol-X2PLPy9JelJOVXXK56j3EKK1j3E84xyfsDkoAUl1PrBB0VmToHkE9WDclHqxDkWS7-6IzRPyCdQ67I_myMdomJ1D1wlHETx9q6ELH__nRFfd_tgH63NZpPmK5Kxra7ehxXQZG9GBFIQeKMaiHKTx64WkvOOcPPjpe0DS9UrB7vH0X0LspPy7S-oPzgwWxevY77-gItIY6Gp0OqjYvrpaqqANwB3TBD5jbu9_ZSZsQVvN5TffVHUqjfGcY35Fdkv2FqSU).\n\nInvestor Relations:\nRyan Schmidt\ninvestors@cloverhealth.com\n\nPress Inquiries:\npress@cloverhealth.com\n\n*Out-of-network/non-contracted providers are under no obligation to treat\nClover members, except in emergency situations.\n\nClover Health is a Preferred Provider Organization (PPO) and a Health\nMaintenance Organization (HMO) with a Medicare contract. Enrollment in Clover\nHealth depends on contract renewal.\n\nY0129_26EX091_M\n\n(1) This analysis focuses on performance by non-SNP PPO plans with over 2,000\nlives as of September 1, 2025 on HEDIS measures applicable to non-SNPs that\nwere used for CMS’s MY 2024 Star ratings, applying the measure ranges used\nby CMS.\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/1a48a25b-b654-4d62-adb3-d1a776346264)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-01T12:00:01.478126465Z","server_sent_at_ms":1790856001478},"received_at":"2026-10-01T12:00:01.527Z","source_url":null},"analysis":{"id":"146680","press_release_id":"158032","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":[],"eventType":"operations_update","narrative":"Clover Health announced its 2027 Medicare Advantage plan offerings, emphasizing $0 to low-premium PPO plans, $0 PCP copays, and preventive care benefits.\n\nThe 2027 geographic footprint is unchanged from 2026, with New Jersey and Georgia remaining core markets; plans will be available to 5.2 million Medicare-eligible beneficiaries across 203 counties in five states.\n\nThe company highlighted that its flagship PPO has ranked #1 nationally on core HEDIS clinical quality measures for two consecutive years, powered by its Clover Assistant platform.\n\nThe annual enrollment period runs October 15 through December 7, 2026; a moderately positive operational update but no new financial disclosures.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Clover holds 2027 MA footprint steady with $0-premium PPO positioning amid industry pullback; watch AEP enrollment results."},"keyFigures":{"customDimensions":{"states":5,"counties":203,"enrollment_period":"October 15 - December 7, 2026","livehealthy_rewards_max":"$400","addressable_beneficiaries":"5.2 million"}},"quotedText":"our ability to pair that flexibility and value with top-ranked clinical quality shows what this model can deliver even as others in the industry pull back","namedEntities":{"people":[{"name":"Jamie Reynoso","role":"CEO of Medicare Advantage at Clover Health"},{"name":"Ryan Schmidt","role":"Investor Relations"}],"products":["Clover Assistant","LiveHealthy Rewards","Medicare Advantage PPO plans"],"companies":[{"name":"Clover Health Investments, Corp.","ticker":"CLOV"},{"name":"Counterpart Health","relationship":"subsidiary"}],"dollarAmounts":[{"amount":"$400","context":"maximum LiveHealthy Rewards for eligible healthy activities"}]},"materialImpact":{"score":2,"reasoning":"Annual plan-year announcement of 2027 Medicare Advantage offerings — consistent footprint and continued PPO focus, but no new financial figures, guidance, or structural change disclosed."},"tickerRelevance":{"others":[],"primary":"CLOV"},"globalImportance":22,"audienceRelevance":30,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap retail favorite","eventGravity":"annual plan-year product announcement","issuerAuthored":true,"retailFavoriteBoost":true}},"event_type":"operations_update","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Clover Health announced its 2027 Medicare Advantage plan offerings, emphasizing $0 to low-premium PPO plans, $0 PCP copays, and preventive care benefits.\n\nThe 2027 geographic footprint is unchanged from 2026, with New Jersey and Georgia remaining core markets; plans will be available to 5.2 million Medicare-eligible beneficiaries across 203 counties in five states.\n\nThe company highlighted that its flagship PPO has ranked #1 nationally on core HEDIS clinical quality measures for two consecutive years, powered by its Clover Assistant platform.\n\nThe annual enrollment period runs October 15 through December 7, 2026; a moderately positive operational update but no new financial disclosures.","key_figures":{"customDimensions":{"states":5,"counties":203,"enrollment_period":"October 15 - December 7, 2026","livehealthy_rewards_max":"$400","addressable_beneficiaries":"5.2 million"}},"named_entities":{"people":[{"name":"Jamie Reynoso","role":"CEO of Medicare Advantage at Clover Health"},{"name":"Ryan Schmidt","role":"Investor Relations"}],"products":["Clover Assistant","LiveHealthy Rewards","Medicare Advantage PPO plans"],"companies":[{"name":"Clover Health Investments, Corp.","ticker":"CLOV"},{"name":"Counterpart Health","relationship":"subsidiary"}],"dollarAmounts":[{"amount":"$400","context":"maximum LiveHealthy Rewards for eligible healthy activities"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-01T12:00:18.920Z","global_importance":22,"audience_relevance":30,"importance_components":{"tickerTier":"small-cap retail favorite","eventGravity":"annual plan-year product announcement","issuerAuthored":true,"retailFavoriteBoost":true}},"durationMs":5269,"modelName":"glm-5.3-flashx"}}